Cyclic Adenosine Glucosamine Glucose Injection

Cyclic adenosine meglumine is a non-digitalis cardiotonic agent with a positive inotropic effect. It can increase myocardial contractility, improve myocardial pump function, dilate blood vessels, and reduce myocardial oxygen consumption. It can improve myocardial cell metabolism and protect ischemic and hypoxic myocardium. It can improve the function of sinoatrial node P cells.

The main ingredient of this product is cycloadenosine meglumine, which is the salt of cycloadenosine meglumine (molar ratio 1:1).

This product is a colorless or almost colorless clear liquid.

It is used for heart failure, myocarditis, sick sinus syndrome, coronary heart disease and cardiomyopathy. It can also be used as an auxiliary treatment for arrhythmia.

Intravenous drip: once a day, 60-180 mg each time.

Occasionally, symptoms such as palpitations, heart palpitations, and dizziness may occur.

1. Those who are allergic to any component of the drug. 2. This product is contraindicated for simultaneous intravenous administration with aminophylline.

This product is contraindicated for simultaneous intravenous administration with aminophylline.

Keep in a dark place and sealed. The validity period is tentatively 12 months.

100ml: 60mg of AMP and 5g of glucose

Hunan Hansen Pharmaceutical Co., Ltd.

• Founded in:

  1998-01-21

• Address:

  No. 2688, Yincheng Avenue, Heshan District, Yiyang City

• Tax NO.:

  91430900MA4L101B51

• Registered Funds:

  503.2 million yuan

• Website:

  Log in to view

• Email:

  Log in to view